Projects Showing 1 - 18 out of 54 results Filter by Program - Any -Asia and Pacific Health ProgramBiosecurity ProgramBiostatistics and Databases ProgramGlobal Health ProgramHIV Epidemiology and Prevention ProgramImmunovirology and Pathogenesis ProgramInfection Analytics ProgramSexual Health ProgramSurveillance and Evaluation Research ProgramTherapeutic and Vaccine Research ProgramViral Hepatitis Clinical Research ProgramViral Hepatitis Epidemiology and Prevention ProgramViral Immunology Systems ProgramYandamanjang First Nations Health Research Program Keywords Focus areas - Any -Aboriginal and Torres Strait Islander healthCOVID-19 and emerging infectionsGlobal healthHIVHPVSexual healthViral hepatitis Research strengths - Any -Biostatistics, modelling and analysisCapacity buildingClinical trials and cohortsEpidemiology and surveillanceHealth economics and health systemsImmunovirologyNew diagnostic approachesPublic health interventionsSocial and behavioural sciences Status - Any -CurrentCompleted View more Sort by Earliest firstLatest firstTitle A - ZTitle Z - A Strategic Treatment Reduction in Very Early liver disease: STRIVE4 STRIVE Trial 1: Shionogi Protease Inhibitor (S-217622) STRIVE Trial 2: Immune Modulation Strategy Trial (IM Strategy) OPTIMAR Optimising metabolic management on integrase based ART STRIDE: Stronger Investments for Infectious Diseases PANTHER Study: Treating anal neoplasia in people living with HIV BRIDGE Bringing RNA Innovations through the Developmental Gap Effectively The CIRCUIT Study Comparing Immunisation-Boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies Study Accurate definition of the underlying HIV-1 reservoir on antiretroviral therapy The ETHOS ENGAGE Study Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings REal World Assessment of people living with Chronic Hepatitis B in Australia (REACH-B) Treatment of HOsPitalised Inpatients for hepatitis C (TOPIC) The DOMINO Study Measuring and mitigating the indirect effects of COVID-19 on tuberculosis and HIV care in Indonesia The TEMPO Study The National Australian HCV Point-of-Care Testing Program Preparing for Injectable PrEP HBV POCT Evaluation of a novel hepatitis B DNA test from capillary blood at the point-of-care as a tool to enhance clinical management Determining the impacts of COVID-19 restrictions on people who use drugs (CODE) Pagination Current page 1 Page 2 Page 3 Next page > Last page >>
The CIRCUIT Study Comparing Immunisation-Boosting Regimens for COVID-19 Upon Initiation of immunosuppressive Therapies Study
The ETHOS ENGAGE Study Enhancing hepatitis C testing and treatment among people who inject drugs in drug treatment settings
The DOMINO Study Measuring and mitigating the indirect effects of COVID-19 on tuberculosis and HIV care in Indonesia
HBV POCT Evaluation of a novel hepatitis B DNA test from capillary blood at the point-of-care as a tool to enhance clinical management
